{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T02:47:18Z","timestamp":1789958838976,"version":"4.0.1"},"reference-count":43,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JBM"],"DOI":"10.2147\/jbm.s395845","type":"journal-article","created":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T00:05:14Z","timestamp":1686614714000},"page":"399-411","source":"Crossref","is-referenced-by-count":7,"title":["Pharmacokinetic-Pharmacodynamic Comparison of Recombinant and Plasma-Derived von Willebrand Factor in Patients with von Willebrand Disease Type 3"],"prefix":"10.2147","volume":"Volume 14","author":[{"given":"Alexander","family":"Bauer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Friberg-Hietala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Smania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Wolfsegger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,6]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1056\/NEJMra1601561","volume":"375","author":"Leebeek","year":"2016","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1056\/NEJMra040403","volume":"351","author":"Mannucci","year":"2004","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1055\/s-2006-949668","volume":"32","author":"Budde","year":"2006","journal-title":"Semin Thromb Hemost"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"225","DOI":"10.5482\/HAMO-14-12-0077","volume":"35","author":"Reininger","year":"2015","journal-title":"Hamostaseologie"},{"key":"ref5","unstructured":"Baxalta US Inc. VONVENDI (von Willebrand factor [recombinant]) lyophilized powder for solution for intravenous injection. Available from: https:\/\/www.fda.gov\/media\/94863\/download. Accessed September 26, 2022."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1182\/blood-2015-02-629873","volume":"126","author":"Gill","year":"2015","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/jth.14313","volume":"17","author":"Peyvandi","year":"2019","journal-title":"J Thromb Haemost"},{"key":"ref8","unstructured":"Baxalta Innovations GmbH. VEYVONDI (vonicog alfa). Summary of product characteristics. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/veyvondi-epar-product-information_en.pdf. Accessed September 26, 2022."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1182\/blood.2021014810","volume":"140","author":"Leebeek","year":"2022","journal-title":"Blood"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1365-2516.2007.01570.x","volume":"13","author":"Bello","year":"2007","journal-title":"Haemophilia"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/j.1365-2516.2007.01616.x","volume":"14","author":"Rivard","year":"2008","journal-title":"Haemophilia"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1046\/j.1351-8216.2003.00809.x","volume":"10","author":"Thompson","year":"2004","journal-title":"Haemophilia"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"944","DOI":"10.3324\/haematol.11124","volume":"92","author":"Federici","year":"2007","journal-title":"Haematologica"},{"key":"ref14","first-page":"1279","volume":"88","author":"Franchini","year":"2003","journal-title":"Haematologica"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1517\/21678707.2016.1171138","volume":"4","author":"Castaman","year":"2016","journal-title":"Expert Opin Orphan Drugs"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"s9","DOI":"10.2450\/2011.003S","volume":"9","author":"Castaman","year":"2011","journal-title":"Blood Transfus"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1111\/hae.13451","volume":"24","author":"Hazendonk","year":"2018","journal-title":"Haemophilia"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1111\/j.1538-7836.2007.02588.x","volume":"5","author":"Lethagen","year":"2007","journal-title":"J Thromb Haemost"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1182\/blood-2013-01-479527","volume":"122","author":"Mannucci","year":"2013","journal-title":"Blood"},{"key":"ref20","unstructured":"European Medicines Agency. Guideline on reporting the results of population pharmacokinetic analyses. CHMP\/EWP\/185990\/06. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-reporting-results-population-pharmacokinetic-analyses_en.pdf. Accessed November 5, 2020."},{"key":"ref21","unstructured":"US Food and Drug Administration. Population pharmacokinetics. Guidance for industry. Available from: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/population-pharmacokinetics. Accessed September 26, 2022."},{"key":"ref22","volume-title":"NONMEM Users\u2019 Guides (1989\u20132014)","year":"2014"},{"key":"ref23","unstructured":"R Foundation for Statistical Computing. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing; 2019."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/jth.14652","volume":"18","author":"de Jager","year":"2020","journal-title":"J Thromb Haemost"},{"key":"ref25","unstructured":"European Medicines Agency. Guideline on the core SPC for human plasma derived von Willebrand factor (CPMP\/BPWG\/278\/02). Available from: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2009\/09\/WC500003423.pdf. Accessed October 5, 2020."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/hae.14046","volume":"26","author":"Srivastava","year":"2020","journal-title":"Haemophilia"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"262","DOI":"10.2450\/2016.0258-15","volume":"14","author":"Favaloro","year":"2016","journal-title":"Blood Transfus"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.transci.2019.08.009","volume":"58","author":"Phua","year":"2019","journal-title":"Transfus Apher Sci"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1182\/bloodadvances.2020003264","volume":"5","author":"Connell","year":"2021","journal-title":"Blood Adv"},{"key":"ref30","volume-title":"StatPearls","year":"2021"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1182\/bloodadvances.2020003891","volume":"5","author":"Bukkems","year":"2021","journal-title":"Blood Adv"},{"key":"ref32","unstructured":"European Medicines Agency. Veyvondi, summary of product characteristics and public assessment report. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/assessment-report\/veyvondi-epar-public-assessment-report_en.pdf. Accessed May 28, 2023."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1111\/hae.14242","volume":"27","author":"Desprez","year":"2021","journal-title":"Haemophilia"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.1055\/s-0037-1617202","volume":"29","author":"Turecek","year":"2009","journal-title":"Hamostaseologie"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1111\/jth.12995","volume":"13","author":"Abshire","year":"2015","journal-title":"J Thromb Haemost"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/j.1365-2516.2012.02916.x","volume":"19","author":"Abshire","year":"2013","journal-title":"Haemophilia"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1097\/01.mbc.0000167659.23262.18","volume":"16","author":"Berntorp","year":"2005","journal-title":"Blood Coagul Fibrinolysis"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1097\/MBC.0000000000000257","volume":"26","author":"Holm","year":"2015","journal-title":"Blood Coagul Fibrinolysis"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1111\/j.1365-2516.2011.02603.x","volume":"17","author":"Raquet","year":"2011","journal-title":"Haemophilia"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/hae.13106","volume":"23","author":"Srivastava","year":"2017","journal-title":"Haemophilia"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1111\/j.1365-2516.2011.02534.x","volume":"17","author":"Gill","year":"2011","journal-title":"Haemophilia"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"100572","DOI":"10.1016\/j.blre.2019.04.001","volume":"38","author":"Peyvandi","year":"2019","journal-title":"Blood Rev"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.2147\/TCRM.S87543","volume":"12","author":"Castaman","year":"2016","journal-title":"Ther Clin Risk Manag"}],"container-title":["Journal of Blood Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=90393","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=90393","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T00:05:20Z","timestamp":1686614720000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/pharmacokinetic-pharmacodynamic-comparison-of-recombinant-and-plasma-d-peer-reviewed-fulltext-article-JBM"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":43,"URL":"https:\/\/doi.org\/10.2147\/jbm.s395845","relation":{},"ISSN":["1179-2736"],"issn-type":[{"value":"1179-2736","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6]]}}}